Do You Need a License to Sell Peptides in Texas?

Nobody issues a document called a peptide license. When an operator asks this question, they are usually asking three unrelated questions at once: whether the business is properly formed and registered to sell anything at all, whether the intended activity touches drug manufacturing, distribution, or dispensing frameworks at the state and federal level, and whether the business is operating inside the research-use-only supply lane in the first place. The first has a routine, procedural answer. The second and third depend entirely on facts specific to your model — who buys from you, how the material is labeled, who takes title, and what you say about it — and those belong to your attorney and the applicable Texas boards, not to an article. Everything below is informational and is not legal advice.

Three separate questions wearing one costume

Before you can research an answer, you have to separate the questions. Most of the confusion in this category comes from collapsing them into one.

The third row is the one that catches people. Operators tend to treat research-use-only as a category their supplier assigned to the product. It is better understood as a description of what the material is for — and that description has to keep matching your actual conduct, or the classification your counsel relied on when they advised you stops describing your business.

The research-use-only lane, and what keeps you inside it

Research-use-only material is supplied to businesses and laboratories for laboratory research. It is not an FDA-approved drug, it is not intended for human or animal consumption, and it carries no dosing information, no administration guidance, and no clinical claims. That is not marketing language — it is the whole basis on which the material moves.

Staying inside that lane is an operational discipline, not a checkbox. In practice it means your product pages, your order forms, your invoices, your packaging, your sales conversations, and your social content all say the same thing the label says. It means you do not publish dosing tables. It means you do not co-package compounds with administration supplies in a way that presents a ready-to-use kit. It means your customer service team has a scripted answer for the question every reseller eventually gets — how do I use this — and that answer is that the material is for laboratory research and the question is outside what the company can address.

The reason this matters procedurally is that regulators generally look at intended use rather than at a single line of label copy. If your public representations point one direction and your label points another, a reasonable regulator or a plaintiff's attorney will ask which one describes the real business. That is a question you want to be able to answer with a stack of consistent documents rather than an explanation.

Intended use is assembled from everything you publish

This is the mechanism worth understanding, because it is where most compliance exposure in this category is created — not at the point of purchase, but afterward, in copy.

Intended use is generally inferred from the totality of what a seller communicates. That includes the obvious things, like a claim that a compound helps with a condition. It also includes the less obvious ones: a testimonial reposted to a story, a blog post that compares compounds by outcome, a bundle name that implies a protocol, an email subject line, a comment reply from an employee account. None of those individually looks like a regulatory statement. Collectively, they can build a picture of a product being offered for something other than research.

The operational consequence is that a peptide catalog needs an internal review step that most product catalogs do not. Someone has to own claim review before copy ships. Someone has to decide what the reply is when a customer asks a use question in a DM. Someone has to keep an archive of what the site said on a given date, because the version of your copy that matters later is the version that was live at the time of the sale.

If that sounds heavy for a small operation, it is still cheaper than the alternative. And it is worth asking your attorney, specifically, which of your existing marketing assets they would want changed before you scale volume. That is a concrete question with a concrete answer, unlike asking whether you need a license.

Distribution, dispensing, and manufacturing are not interchangeable words

Operators frequently use these three terms as synonyms. Regulatory frameworks generally do not, and the distinctions tend to drive which permit, registration, or licensed professional is implicated.

Ask your counsel to tell you, in writing, which of these your model looks like. A few facts usually decide it: whether you take physical possession of inventory or drop-ship, whether you open, repackage, relabel, or reconstitute anything, whether you sell only business-to-business or also to individuals, whether you sell across state lines, and whether any licensed professional is involved in the transaction chain.

Repackaging deserves particular attention. In many regulatory frameworks, altering a product's container or label is treated very differently from reselling it as received — in some cases it can move a business into a category with far heavier obligations. That is a general pattern, not a Texas-specific rule, and it is exactly the kind of point to verify with counsel and the relevant board rather than assume. If your plan involves your own branded labels on someone else's material, raise it explicitly and early, because it can change the shape of the whole business.

What to put in front of your attorney

Most operators get a vague answer from counsel because they asked a vague question. Bring a written description of the model instead, covering:

• Who the buyer is, and how you verify that they are a business rather than a consumer
• Whether you hold inventory, drop-ship, or both, and who holds title at each step
• Whether you relabel, repackage, or alter anything at any point
• Every state you intend to ship into, not just your home state
• Your full claim inventory: site copy, ads, email, social, packaging inserts
• What documentation you can produce per lot if someone asks for it
• Whether any licensed professional is part of your transaction chain, and in what role

Then ask three direct questions: which registrations or permits, if any, apply to this model in this state; what would have to change about the model for a different answer; and what records should be retained, in what form, and for how long. Also ask which state board or agency is the right one to contact for a written position, because state specifics vary and a general answer is not the same as the answer for your facts. Check with your own counsel and the applicable Texas board before you rely on anything here.

Supplier vetting belongs in your compliance file

Whichever answers you get, one obligation is constant: you should be able to prove what is in the vials you sell. That is a sourcing decision, and it is worth treating as a compliance step rather than a purchasing one.

What to verify before you place a first order:

• Lot-matched certificates of analysis. A generic COA for a compound is not evidence about the vial in your hand. The document should tie to the specific lot you received.
• Whether COAs are public or gated. Some suppliers charge for test documentation or release it only after purchase. If you cannot see the results before you buy, you cannot evaluate the supplier — you can only hope.
• What was actually tested. Purity by HPLC is one measure. Identity confirmation and contamination screening are different measures. Ask what the panel covers, not just what the headline number is.
• Transparent pricing and tier structure. Programs that hide pricing behind a sales call make it impossible to model a catalog before committing time to it. Margins in this category vary widely with volume, category, and how you position the line, so you need real numbers to plan against, not a promise of good ones.
• Fulfillment geography and consistency. Where orders ship from affects timelines and how much of your working capital sits in transit.

These are also the questions your attorney will ask you when they build your file. Having documented answers already is faster than reconstructing them later.

What Real Peptides does differently

Real Peptides supplies research-use-only compounds to businesses through its Wholesale Partner Program. Material is produced to 99%+ HPLC purity and batch tested across a defined analytical panel, and the certificates of analysis are published so a prospective buyer can read the lab results before deciding anything — including on individual listings such as BPC-157 10mg and across the broader popular peptides catalog. Test documentation is not a paid add-on and is not held back until after an order.

Fulfillment is handled from within the United States with orders shipping in 5–7 days, which makes replenishment planning something you can build a stocking model around. The Wholesale Partner Program application is a three-step process: submit the application with your business details, get reviewed for approval, and start ordering at partner pricing once approved. Pricing tiers are shown rather than negotiated behind a call.

None of this substitutes for your own licensing analysis. A supplier can give you documentation, consistent supply, and transparent terms. It cannot tell you which registrations apply to your business, and any supplier that offers to is telling you something they are not in a position to know.

Where a qualified buyer goes next

If you have your entity in place, you have run the licensing question past counsel for your specific model, and you are ready to evaluate supply on documentation rather than on a sales pitch, the next step is the wholesale application — where the review process and partner pricing tiers are laid out in full.

For more on the program structure and tiers, see the wholesale peptides program; for the broader licensing overview beyond one state, read do you need a license to sell peptides; and when you are ready, apply for a wholesale account.